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Background: Despite the widespread application of Symptom Checklist 90-R (SCL-90-R), its psychometric
weaknesses have repeatedly been noted. This study aimed to comparatively assess the psychometric properties of
the SCL-90-R scales and the scales of its short versions Brief Symptom Inventory (BSI), Symptom Checklist-27
(SCL-27), Brief Symptom Inventory-18 (BSI-18), Symptom Checklist-14 (SCL-14), and Symptom Checklist short
version-9 (SCL-K-9) in patients with affective disorders.
Methods: The data of 2,727 patients within the main treatment group of affective disorders were assessed
according to the DSM-IV. Patients completed the SCL-90-R and Beck Depression Inventory (BDI).
Results: There were no significant differences regarding the internal consistency of the SCL-90-R scales and the
scales of the short versions. The dimensional structure was only supported for the short versions BSI-18, SCL-14
and SCL-K-9. The assessment of convergent validity revealed high correlations. With regard to the discriminant
validity, there were medium correlations. With regard to the sensitivity of change, no significant differences
between the scales were found.
Conclusions: In summary, the scales of the short versions show mostly satisfactory psychometric properties in
comparison to the scales of the SCL-90-R. The results support the application of the short versions as screening
instruments, especially the BSI-18, and more economic variants of the SCL-90-R covering a wide range of
psychopathological symptoms.
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The Symptom Checklist 90-R (SCL-90-R) [1] is a widely
applied self-assessment instrument for a broad range of
mental disorders that assesses the subjective symptom
burden in patients with mental disorders. Alongside the
high acceptance and extensive worldwide application of
the instrument as an outcome instrument in the treat-
ment of patients with affective disorders, a number of
studies have highlighted the psychometric weaknesses of
the SCL-90-R. A central criticism is that many studies
were unable to replicate the postulated factor structure
and instead found a general factor with large variance* Correspondence: sandreas@uke.de
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reproduction in any medium, provided the or[2,3]. This finding is relevant with regard to the practi-
cality of the instrument because results on the factorial
validity suggest partial redundancy of the collected data.
The development of numerous short versions of the
SCL-90-R indicates the need for a more economic in-
strument. The short versions of the SCL-90-R [4] that
have been developed include either a reduced number of
items referencing the postulated factor structure, such as
the Brief Symptom Inventory (BSI-53) [5] and Brief
Symptom Inventory-18 (BSI-18) [6], or a reduced item
number with a reduced factor structure, such as the
SCL-27 [7] and SCL-14 [8]. Other SCL-90-R short ver-
sions with a considerably reduced item number measure
only a general severity factor, such as the SCL-K-9
[9,10]. Table 1 gives an overview of each short versiond. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Dimensional structure of the SCL-90-R and its short versions BSI, SCL-27, BSI-18, SCL-14 and SCL-K-9
Questionnaire Dimension Number of items Item position in the SCL-90-R
SCL-90-R Somatization 12 1, 4, 12, 27, 40, 42, 48, 49, 52, 53, 56, 58
Obsessive compulsive 10 3, 9, 10, 28, 38, 45, 46, 51, 55, 65
Interpersonal sensitivity 9 6, 21, 34, 36, 37, 41, 61, 69, 73
Depression 13 5, 14, 15, 20, 22, 26, 29, 30, 31, 32, 54, 71, 79
Anxiety 10 2, 17, 23, 33, 39, 57, 72, 78, 80, 86
Hostility 6 11, 24, 63, 67, 74, 81
Phobic anxiety 7 13, 25, 47, 50, 70, 75, 82
Paranoid ideation 6 8, 18, 43, 68, 76, 83
Psychoticism 10 7, 16, 35, 62, 77, 84, 85, 87, 88, 90
Additional items 7 19, 44, 59, 60, 64, 66, 89
BSI Somatization 7 4, 12, 40, 48, 49, 52, 56
Obsessive compulsive 6 9, 28, 45, 46, 51, 55
Interpersonal sensitivity 4 34, 37, 41, 69
Depression 6 15, 29, 30, 32, 54, 79
Anxiety 6 2, 23, 33, 57, 72, 78
Hostility 5 11, 24, 63, 67, 74
Phobic anxiety 5 13, 47, 50, 70, 75
Paranoid ideation 5 8, 18, 43, 76, 83
Psychoticism 5 7, 77, 85, 88, 90
Additional items 4 19, 44, 59, 89
SCL-27 Depressive symptoms 4 15, 30, 54, 59
Dysthymic symptoms 4 9, 14, 51, 55
Vegetative symptoms 6 4, 39, 40, 48, 49, 53
Agoraphobic symptoms 5 13, 25, 33, 50, 82
Symptoms of social phobia 4 37, 41, 61, 69
Symptoms of mistrust 4 18, 68, 76, 83
BSI-18 Somatization 6 12, 40, 48, 52, 56, 58
Depression 6 15, 29, 30, 32, 54, 79
Anxiety 6 2, 33, 57, 72, 78, 86
SCL-14 Depression 6 26, 28, 30, 54, 77, 79
Phobic anxiety 4 13, 25, 47, 82
Somatization 4 42, 52, 56, 58
SCL-K-9 Global Severity Index 9 24, 28, 31, 34, 43, 57, 58, 75, 77
Notes: SCL-90-R = Symptom Checklist 90-R [4]; BSI = Brief Symptom Inventory [6]; SCL-27 = Symptom Checklist-27 [7]; BSI-18 = Brief Symptom Inventory 18 [6];
SCL-14 = Symptom Checklist 14 [8]; SCL-K-9 = Symptom Checklist-short version-9 [10].
Prinz et al. BMC Psychiatry 2013, 13:104 Page 2 of 9
http://www.biomedcentral.com/1471-244X/13/104with their respective scales and item positions compared
to the SCL-90-R.
There are some comparative studies available assessing
the validity of individual short versions in different set-
tings. One study by Müller et al. (2010) examined the
psychometric properties of eleven short versions of the
SCL-90-R in a sample of 100 German mothers of young
children treated at a child psychiatric family day clinic.
Müller et al. [11] concluded that compared to the other
short versions, the SCL-10S is a good screening instru-
ment, but further research on larger samples is needed.Another study conducted by the authors of this paper
[12] more generally examined the psychometric proper-
ties of short versions of the SCL-90-R in a large sample
(N = 8,581) of inpatients with various mental disorders.
Compared to the subscales of the SCL-90-R, the sub-
scales of the short versions of the SCL-90-R showed sat-
isfactory psychometric properties in various mental
disorders. The results supported the implementation of
the short versions BSI, SCL-27, SCL-14, and - within
limits - SCL-K-9 as suitable screening instruments to as-
sess a wide range of psychopathologic symptoms.
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the prevalence rate of affective disorders ranges from
6.6% [13] to 11.9% [14]. Not only are affective disorders
a highly prevalent disorder in the general population,
people with affective disorders comprise one of the lar-
gest patient groups in inpatient and outpatient psycho-
therapeutic settings [15]. No empirical data on the
appropriateness of the SCL-90-R and its short versions
within this large diagnosis group exist.
Therefore, the aim of this study was to assess the
psychometric properties (reliability, convergent and dis-
criminant validity, and sensitivity to change) of the SCL-
90-R scales (including the global severity index, GSI)
and the scales of the short forms (BSI, SCL-27, BSI-18,
SCL-14, and SCL-K-9) in patients with affective disor-
ders. This study should also add substantial information
on the concurrent validity of the SCL-90-R and its short
versions in patients within the most prevalent subgroup
of affective disorders.Methods
Design and setting
This study was conducted at one of the largest clinics
for inpatients with mental disorders in Germany be-
tween 2000 and 2003. The clinic concept comprises
mainly cognitive-behavioural therapy. Patients (N = 2,727)
were consecutively included in the study after providing
written informed consent. The study was conducted in
line with the Code of Ethics of the World Medical Associ-
ation (Declaration of Helsinki, 1964) and approved by
the institutional review board of the Schoen Hospital
Company.
The patients routinely completed the SCL-90-R and
the Beck Depression Inventory (BDI) [16] at the begin-
ning and end of treatment. The average treatment dur-
ation was 48 days (SD = 18 days). Post-hoc, the items of
the BSI, SCL-27, BSI-18, SCL-14, and SCL-K-9 were
extracted from the long version of the SCL-90-R.Sample
The mean age of the sample was 51 years (SD = 12 years,
range 23–91 years): 67% of the patients were female,
49% were married, 30% were single, and 17% were di-
vorced. The largest group of patients had German-
equivalent secondary school-level education, 31% had
CSE level, and 25% had A-level education.
The therapists diagnosed the patients according to
DSM-IV [17] criteria at the end of treatment. Most of
the patients suffered from recurrent major depressive
disorder (n = 1,606, 59%), followed by major depressive
disorder, single episode (n = 922, 34%), dysthymic dis-
order (n = 130, 5%), and depressive disorder not other-
wise specified (n = 69, 3%).Instruments
The instruments applied in this study were the German
version of the SCL-90-R [18] and the German version of
the Beck Depression Inventory [19], a widely applied
and well-known disorder-specific self-report instrument
that assesses the severity of depression symptoms.
Retaining the five-level Likert scale from >> 0 = none at
all to 4 = very severe, the following short versions were
extracted from the SCL-90-R scales post-hoc (see
Table 1): BSI [18], BSI-18 [6], SCL-27 [7], SCL-14 [8],
and SCL-K-9 [10].
Statistical analyses
With regard to reliability, the internal consistencies of
the subscales of the SCL-90-R and the subscales of the
short versions (BSI, SCL-27, BSI-18, SCL-14, and
SCL-K-9) were calculated using the Cronbach´s alpha
reliability coefficient. Cronbach´s alpha values of α ≥ 0.70
are interpreted as satisfactory [20]. All coefficients of the
SCL-90-R scales and scales of the corresponding short
forms (BSI, SCL-27, BSI-18, SCL-14, and SCL-K-9) were
assessed for significant differences based on Fisher´s
z-tests.
To assess the factorial validity of the SCL-90-R scales
and scales of the short forms (BSI, SCL-27, BSI-18, SCL-
14, SCL-K-9), confirmatory factor analyses (CFAs) were
calculated using the AMOS 4.0 software package (Analysis
of Moment Structures) [21]. Confirmatory factor analysis
was conducted to assess whether the scales postulated by
the test authors could be replicated. Moreover, fit indices
(standardised root mean square residual (SRMR), root
mean square error of approximation (RMSEA), and com-
parative fit index (CFI)) were calculated according to Hu
and Bentler (1999). The recommended cut-off values were
the following: RMSEA ≤ 0.06, SRMR ≤ 0.08 (or 0.10), and
CFI ≥ 0.95 [22]. Missing data (5% total missing data at
time point t1) were replaced using the expectation-
maximisation algorithm (EM algorithm) [23].
The mean value differences and correlations were cal-
culated to assess the equivalence of the SCL-90-R and
its short versions. It was expected that the scales and the
total score of the short versions would on the one
hand significantly differ from and on the other hand
correlate highly with the scales and the total score of
the SCL-90-R long version. To assess the size of the
corresponding mean value difference, effect sizes were cal-
culated as follows: deffect size =Mpre–Mpost/SDpooled [24].
To assess the convergent validity correlations, Pearson
product–moment correlations were calculated between
the depression scale of the SCL-90-R, the depression
subscales of the short versions (BSI, SCL-27, BSI-18,
SCL-14, and SCL-K-9) and the BDI total score. There-
fore, significant correlations with large effect sizes were
expected. The size of the correlations was based on the
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0.10 > r < 0.30, small effect size; 0.30 > r < 0.50, medium
effect size and r > 0.50, large effect size.
To assess the discriminant validity correlations be-
tween all other subscales of the SCL-90-R and its sub-
scales with the BDI, the total score was calculated. It
was expected that the correlation between the SCL-90-R
and the short version scales with the total BDI score
would show only small effect sizes (r < 0.30).
To assess the sensitivity to change, the mean value dif-
ferences in SCL-90-R scales and the short version scales
(BSI, SCL-27, BSI-18, SCL-14, and SCL-K-9) between
patient admission to and discharge from the clinic were
calculated. Cohen’s d [24] was chosen as a measure of
the effect size and calculated according to the following
formula: deffect size =Mpre–Mpost/SDpre. The effect sizes
were interpreted as follows: 0.20 > d < 0.50, small effect
size; 0.50 > d < 0.80, medium effect size and d > 0.80,
large effect size.
Results
Reliability of the short forms in comparison to the
SCL-90-R
Internal consistencies were calculated to assess reliabil-
ity. Overall, the internal consistencies of the SCL-90-R
scales ranged from α = 0.74 (“aggression”) to α = 0.97
(GSI) and were thus regarded as satisfactory. The values
of the BSI scales ranged from α = 0.67 (“aggression”) to
α = 0.96 (GSI) and were thus, on average, slightly lower
than those of the SCL-90-R but could also be regarded
satisfactory. A similar picture emerged for the SCL-27
scales (α = 0.73 “mistrust” to α = 0.93 “GSI”). The in-
ternal consistencies of the BSI-18 and SCL-14 scales
showed consistently satisfactory results (BSI-18: α = 0.79
“somatisation” to α = 0.90 “GSI”; SCL-14: α = 0.81
“somatisation” to α = 0.88 “GSI“), which was similar to
the GSI of the SCL-K-9 (α = 0.87). No significant differ-
ences were found between the internal consistencies of
the compared scales in a psychometric examination of
the calculated coefficients using Fisher´s z-test based on
the large sample size used (see Table 2).
Factorial validity of the short forms compared to the
SCL-90-R
Table 3 displays the results of the confirmatory factor
analysis. Examining the fit indices, the RMSEA (0.06)
and the SRMR (0.06) showed a satisfactory model fit for
the SCL-90-R scale structure in patients with affective
disorders [22]; however, the CFI (0.75) was markedly
outside the cut-off limits [22].
Moreover, the assessment of the BSI scale structure in
patients with affective disorders did not reveal a
homogenous picture. The RMSEA (0.06) and the SRMR
value (0.05) were outside the acceptable range, whereasthe CFI (0.83) was outside the cut-off value of ~ 0.95
(see Table 3).
Furthermore, the six-dimensional scale structure of
the SCL-27 was not adequately confirmed in patients
with affective disorders, although the RMSEA (0.06) and
the CFI (0.90) were only marginally outside the range
defined by the cut-off values. The SRMR (0.05) was
within the accepted range (see Table 3). With regard to
the BSI-18, satisfactory cut-off values were confirmed.
The postulated scale structure of the SCL-14 was repli-
cated using confirmatory factor analysis, as all three in-
dices were within the expected range (see Table 3).
Additionally, the one-dimensional scale structure of
the SCL-K-9 was supported with confirmatory factor
analysis; although the RMSEA (0.07) was marginally
above the cut-off values, the other two indices lay within
the expected range (see Table 3). We provided additional
material on the covariance matrix for the SCL-90-R and
their short versions of the confirmatory factor analyses
(please see Additional files 1, 2, 3, 4, 5 and 6 as PDF).
Equivalence of the short forms with the SCL-90-R
With regard to the equivalence of the short versions and
the SCL-90-R in patients with affective disorders, paired
t-tests showed significant mean value differences in all
symptom scales and the global GSI index between the
SCL-90-R scales and the corresponding scales of the
BSI, SCL-27, BSI-18, SCL-14, and SCL-K-9 (see Table 4).
To assess the practical significance, effect sizes of the
calculated mean value differences were also calculated.
Excluding “psychotic” and “insecurity in social contacts”
(comparing SCL-90-R and BSI), “compulsiveness” and
“depression” (comparing SCL-90-R and SCL-27), “de-
pression” and “phobic anxiety” (comparing SCL-90-R
and –SCL-14), and the global GSI index (comparing
SCL-90-R and SCL-K-9), the scale differences showed
small effect sizes (ES d < 0.20) (see Table 4). A medium
effect was only found for the comparison of the total
GSI value of the SCL-90-R and the SCL-K-9 (d = 0.62).
Consistently high correlations were found between the
subscales of the SCL-90-R and the subscales of the in-
vestigated short forms (r = 0.85 - 0.98).
Convergent and discriminant validity of the short forms
compared to the SCL-90-R
The assessment of convergent validity showed a statisti-
cally significant correlation between the BDI total score
and the SCL-90-R depression scale in patients with
affective disorders (r = 0.80, see Table 5). The BDI total
score was slightly less correlated with the BSI depression
scale (r = 0.77); however, it was still fairly high overall. The
depression scale of the SCL-27 showed a significantly high
correlation with the BDI total score (r = 0.71). Similar to
the BSI, the BSI-18 also showed a high correlation with
Table 2 Comparison of internal consistencies (Cronbach´s alpha) of the SCL-90-R subscales and the short versions
BSI, SCL-27, BSI-18, SCL-14 and SCL-K-9 in patients with affective disorder













SOMA 0.86 12 SOMA 0.80 7 VEG 0.77 6 SOMA 0.79 6 VEG 0.81 4
OCD 0.87 10 OCD 0.84 6 DYS 0.85 4
INT 0.87 9 INT 0.79 4 SOP 0.84 4
DEPR 0.89 13 DEPR 0.85 6 DEP 0.79 4 DEPR 0.85 6 DEP 0.87 6
ANX 0.87 10 ANX 0.82 6 ANX 0.82 6
HOST 0.74 6 HOST 0.67 5
PHOB 0.84 7 PHOB 0.79 5 AGO 0.81 5 AGO 0.81 4
PARA 0.76 6 PARA 0.74 5 MIS 0.73 4
PSYC 0.78 10 PSYC 0.70 5
GSI 0.97 83 GSI 0.96 49 GSI 0.93 27 GSI 0.90 18 GSI 0.88 14 GSI 0.84 9
Notes: Abbreviations of the SCL-90-R, BSI and BSI-18: SOMA = Somatization; OCD = obsessive-compulsive; INT = interpersonal sensitivity; DEPR = Depression; ANX =
Anxiety; HOST = Hostility; PHOB = Phobic Anxiety; PARA = Paranoid Ideation; PSYC = Psychoticism; GSI = Global Severity Index; Abbreviations of the SCL-27: DEP =
Depressive symptoms; DYS = Dysthymic symptoms; VEG = Vegetative symptoms; AGO = Agoraphobic symptoms; SOP = Symptoms of social phobia; MIS =
Symptoms of mistrust; GSI = Global Severity Index; Abbreviations of the SCL-14: DEP = Depression; PHO = Phobic Anxiety; SOM = Somatization; GSI = Global
Severity Index; Abbreviations of the SCL-K-9: GSI = Global Severity Index. 2621 ≤N ≤ 2632.
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BDI total score and the SCL-14 depression scale was also
very high. The depression item of the SCL-K-9 was corre-
lated with the BDI total score and, as expected, displayed
a medium correlation of r = 0.51 (see Table 5).
With regard to discriminant validity, theoretically
expected low correlations were not found, but only for
the SCL-14 and the BSI-18 we found lower correlations
(see Table 5). For example, there was a medium correl-
ation between the somatisation scale of the SCL-90-R,
BSI, SCL-27, and BSI-18 and the BDI total score (r =
0.49 to r = 0.51). The construct-unrelated scales of the
SCL-14, however, showed low correlations with the BDI
total score (r = 0.41 “SCL-14 phobic anxiety”, r = 0.41
“SCL-14 somatisation”).
An assessment of the correlation coefficient using
Fisher`s z-test revealed that due to the large sample size,
even small deviations of 0.01 resulted in statistically sig-




SCL-90-R 31074.113 3284 .000
BSI 11443.895 1091 .000
SCL-27 3351.461 309 .000
BSI-18 1490.482 132 .000
SCL-14 557.444 74 .000
SCL-K-9 382.378 27 .000
Notes: χ2 = Chi-square; df = Degrees of Freedom; RMSEA = Root-Mean-Square-
Standardized-Root-Mean-Square-Residual; a = in a sample size of N > 250 theSensitivity to change of the short versions compared to
the SCL-90-R
An assessment of the sensitivity to change showed only
one larger deviation for the SCL-27 of pre-post effect
sizes (see Table 6) compared to the effect size of the
SCL-90-R. The others ranged between d = 0.67 and d =
0.68 in patients with affective disorders. The second sub-
stantial difference was found in the value of the effect
sizes for the “phobic anxiety” subscale of the SCL-90-R
(d = 0.39), BSI (d = 0.41), and SCL-14 (d = 0.28). For all
other scales, the comparisons showed only minor differ-
ences in calculated effect sizes (see Table 6).
Discussion
This study investigated the psychometric properties of
the German version of the SCL-90-R [18] and its short
versions, the BSI [25], SCL-27 [7], BSI-18 [6], SCL-14
[8], and SCL-K-9 [10], in a large sample of 2,727 inpa-
tients with affective disorders.sions (BSI, SCL-27, BSI-18, SCL-14 and SCL-K-9) in patients







Error-of-Approximation; CFI = Comparative-Fit-Index; SRMR =
Cut-off is 0.06, in N < 250 the Cut-off is 0.08 [22]. N = 2727.
Table 4 Means (M) and standard deviations (SD) of the 9
scales and the GSI of the SCL-90-R and the short
versions: BSI, SCL-27, BSI-18, SCL-14, SCL-K-9 and the
results of the t-tests, effect sizes and correlations in
patients with affective disorders
SCL-90-R BSI
Scale M SD Scale M SD t ES r
SOMA 1.12 0.74 SOMA 1.00 0.75 25.37* 0.16 0.95
OCD 1.57 0.81 OCD 1.74 0.92 −34.65* −0.20 0.96
INT 1.40 0.87 INT 1.61 0.99 −33.18* −0.23 0.95
DEPR 1.73 0.83 DEPR 1.69 0.97 6.07* 0.05 0.94
ANX 1.27 0.80 ANX 1.41 0.85 −30.10* −0.17 0.96
HOST 0.89 0.71 HOST 0.95 0.71 −19.73* −0.08 0.98
PHOB 0.89 0.85 PHOB 0.99 0.91 −24.69* −0.11 0.98
PARA 1.13 0.82 PARA 1.20 0.88 −22.80* −0.08 0.98
PSYC 0.83 0.63 PSYC 1.07 0.82 −37.22* −0.32 0.93
GSI 1.26 0.64 GSI 1.30 0.67 −22.63* −0.07 0.99
SCL-90-R SCL-27
SOMA 1.12 0.74 VEG 1.03 0.78 12.51* 0.12 0.88
OCD 1.57 0.81 DYS 1.83 1.04 −26.49* −0.28 0.88
INT 1.40 0.87 SOP 1.43 1.04 −3.92* −0.03 0.94
DEPR 1.73 0.83 DEP 1.40 0.93 34.28* 0.37 0.85
PHOB 0.89 0.85 AGO 0.86 0.86 5.07* 0.04 0.94
PARA 1.13 0.82 MIS 1.13 0.90 1.14a 0.01 0.95
GSI 1.26 0.64 GSI 1.27 0.71 −4.04* −0.02 0.97
BSI 18
SOMA SOM 1.01 0.80 20.71* 0.14 0.94
DEPR DEP 1.69 0.97 6.07* 0.04 0.94
ANX ANX 1.44 0.87 −37.90* −0.20 0.97
GSI GSI 1.38 0.74 −24.44* −0.17 0.94
SCL-90-R SCL-14
SOMA 1.12 0.74 SOM 1.18 0.97 −6.27* −0.07 0.88
DEPR 1.73 0.83 DEP 1.93 1.00 −28.04* −0.22 0.94
PHOB 0.89 0.85 PHO 0.65 0.87 37.15* 0.28 0.93
GSI 1.26 0.64 GSI 1.35 0.75 −15.36* −0.13 0.92
SCL-90-R SCL-K-9
GSI 1.26 0.64 GSI 1.71 0.83 −64.25* −0.62 0.91
Notes: Abbreviations of the SCL-90-R, BSI and BSI-18: SOMA = Somatization;
OCD = obsessive-compulsive; INT = interpersonal sensitivity; DEPR = Depression;
ANX = Anxiety; HOST = Hostility; PHOB = Phobic Anxiety; PARA = Paranoid
Ideation; PSYC = Psychoticism; GSI = Global Severity Index; Abbreviations of the
SCL-27: DEP = Depressive symptoms; DYS = Dysthymic symptoms; VEG =
Vegetative symptoms; AGO = Agoraphobic symptoms; SOP = Symptoms of
social phobia; MIS = Symptoms of mistrust; GSI = Global Severity Index;
Abbreviations of the SCL-14: DEP = Depression; PHO = Phobic Anxiety; SOM =
Somatization; GSI = Global Severity Index; Abbreviations of the SCL-K-9: GSI =
Global Severity Index. * Correlations are significant at p < 0.05 (2-tailed).
a Correlation is not significant. 2637 ≤N ≤ 2638.
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garding the internal consistencies of the SCL-90-R and
its short versions was expected. The calculated internal
consistencies of the short forms were within a satisfac-
tory range compared to the SCL-90-R and corresponded
to reliability values reported by Derogatis [6], except for
the BSI aggression scale (α=0.67). As expected, the reli-
ability values were decreased with decreasing item num-
bers but highest for the GSI of the SCL-90-R and its
short versions.
Regarding the factorial validity, the originally postu-
lated scale structure of the SCL-90-R by Derogatis [4]
was not supported in this study on patients with
affective disorders, which is in line with numerous previ-
ous studies [2,26,27]. Furthermore, the assessment of the
BSI scale structure showed an insufficient model fit,
leading to a rejection of the postulated model. Fit indices
of the SCL-27 scale structure supported a better fit of
the scale structure but were not regarded as satisfactory.
These results were largely in agreement with findings of
Hardt et al. [7]. The BSI-18 also showed largely satisfac-
tory results regarding its factorial validity in patients
with affective disorders.
In line with the findings of Harfst et al. [8], confirmatory
factor analysis of the SCL-14 supported the postulated
scale structure in the present study. The one-dimensional
scale structure of the SCL-K-9 and the dimensional scale
structure of the BSI-18 were also supported in confirma-
tory factor analysis. Overall, a good model fit was only
reported for the BSI-18, SCL-14 and SCL-K-9 short forms.
Therefore, the factorial validity of the SCL-90-R, BSI and
SCL-27 remains questionable.
An assessment of the equivalence of scale values of
the short versions and the SCL-90-R in patients with
affective disorders showed, as expected, no significant
differences. The only exception was the divergence
between the GSI of the SCL-90-R and the SCL-K-9,
which showed a medium effect size (d = 0.62). Overall, it
can be concluded that the symptom severity values of
the SCL-90-R scales are comparable to values of the
short versions.
The convergent validity of the SCL-90-R and its
short versions can be regarded as satisfactory. There
were consistently significant correlations with at least
large effect sizes. These results support the suitability
of the SCL-90-R short versions as a screening instru-
ment to cover a wide range of psychopathological
symptoms in patients with affective disorders without
a substantial loss of information.
Similar to the findings of the factorial validity of the
SCL-90-R and the majority of its short versions, the dis-
criminant validity was also not regarded as satisfactory.
The only exception was the SCL-14 [8], in which the two
subscales “somatisation“ and “phobic anxiety“correlated
Table 5 Convergent validity: (Product–moment-Correlations) between the scales of the SCL-90-R, BSI, SCL-27, BSI-18,
SCL-14 and SCL-K-9 and the total score of the Beck-Depression-Inventory (BDI, Hautzinger et al., 1995) in patients with
affective disorders
SCL-90-R BSI SCL-27 BSI-18 SCL-14 SCL-K-9
Scale r Scale r Scale r Scale r Scale r Scale r
SOMA 0.51** SOMA 0.50** VEG 0.50** SOMA 0.49** SOMA 0.41**
OCD 0.68** OCD 0.66** DYS 0.61**
INT 0.65** INT 0,64** SOP 0.60**
DEPR 0.80** DEPR 0.77** DEP 0.71** DEPR 0.77** DEPR 0.79** itemD 0.51**
ANX 0.61** ANX 0.58** ANX 0.59**
HOST 0.49** HOST 0.49**
PHOB 0.51** PHOB 0.52** AGO 0.52** PHOB 0.41**
PARA 0.52** PARA 0.52** MIS 0.50**
PSYC 0.65** PSYC 0.66**
GSI 0.77** GSI 0.77** GSI 0.75** GSI 0.74** GSI 0.74** GSI 0.69**
Notes: Abbreviations of the SCL-90-R, BSI and BSI-18: SOMA = Somatization; OCD = obsessive-compulsive; INT = interpersonal sensitivity; DEPR = Depression; ANX =
Anxiety; HOST = Hostility; PHOB = Phobic Anxiety; PARA = Paranoid Ideation; PSYC = Psychoticism; GSI = Global Severity Index; Abbreviations of the SCL-27: DEP =
Depressive symptoms; DYS = Dysthymic symptoms; VEG = Vegetative symptoms; AGO = Agoraphobic symptoms; SOP = Symptoms of social phobia; MIS =
Symptoms of mistrust; GSI = Global Severity Index; Abbreviations of the SCL-14: DEP = Depression; PHO = Phobic Anxiety; SOM = Somatization; GSI = Global
Severity Index; Abbreviations of the SCL-K-9: GSI = Global Severity Index. ** Correlations are significant at p < 0.01 (2-tailed). 2601 ≤N ≤ 2689.
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ation was still of at least medium effect size, it was none-
theless substantially lower in comparison to the scales of
the short versions and the SCL-90-R. Therefore, the dis-
criminant validity of the SCL-90-R and its short versions
in patients with affective disorders cannot be regarded as
satisfactory.
The assessment of sensitivity to change was expected to
show no marked difference between the SCL-90-R and its
short versions in patients with affective disorders. The re-
sults of sensitivity to change showed only small differencesTable 6 Mean pre-post effect sizes (d) for scales of the SCL-90
SCL-K-9 in patients with affective disorders
SCL-90-R BSI SCL-27
Scale d Scale d Scale d
SOMA 0.37 SOMA 0.34 VEG 0.35
OCD 0.61 OCD 0.58 DYS 0.54
INT 0.52 INT 0.54 SOP 0.52
DEPR 0.72 DEPR 0.67 DEP 0.52
ANX 0.47 ANX 0.51
HOST 0.37 HOST 0.40
PHOB 0.39 PHOB 0.41 AGO 0.37
PARA 0.46 PARA 0.47 MIS 0.40
PSYC 0.44 PSYC 0.43
GSI 0.62 GSI 0.63 GSI 0.59
Notes: Abbreviations of the SCL-90-R, BSI and BSI-18: SOMA = Somatization; OCD = o
Anxiety; HOST = Hostility; PHOB = Phobic Anxiety; PARA = Paranoid Ideation; PSYC =
Depressive symptoms; DYS = Dysthymic symptoms; VEG = Vegetative symptoms; AG
Symptoms of mistrust; GSI = Global Severity Index; Abbreviations of the SCL-14: DEP
Severity Index; Abbreviations of the SCL-K-9: GSI = Global Severity Index. d = effect sin the calculated effect size comparisons of the different
scales and the GSI of the SCL-90-R and its short versions
BSI, SCL-27, BSI-18, SCL-14 and SCL-K-9 and were thus
regarded as non-significant. Thus, the short versions BSI,
SCL-27, BSI-18, SCL-14, and SCL-K-9 are suitable for pa-
tients with affective disorders and are similarly appropriate
to detect sensitivity to change as the SCL-90-R. Moreover,
the results showed, as expected, that effect sizes of the
SCL-90-R depression scale and its short versions were
highest compared to other scales (e.g., the somatisation
scale), excluding the SCL-27 [7]. This finding supports the-R and the short versions BSI, SCL-27, BSI-18, SCL-14 and
BSI-18 SCL-14 SCL-K-9
Scale d Scale d Scale d
SOMA 0.33 SOMA 0.29
DEPR 0.67 DEPR 0.68
ANX 0.51
PHOB 0.28
GSI 0.61 GSI 0.59 GSI 0.63
bsessive-compulsive; INT = interpersonal sensitivity; DEPR = Depression; ANX =
Psychoticism; GSI = Global Severity Index; Abbreviations of the SCL-27: DEP =
O = Agoraphobic symptoms; SOP = Symptoms of social phobia; MIS =
= Depression; PHO = Phobic Anxiety; SOM = Somatization; GSI = Global
ize. 2290 ≤ N ≤ 2294.
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outcome measure instruments in patients with affective
disorders.
Overall, it can be concluded that the short versions are
a more economic variant of the SCL-90-R, although for
the SCL-90-R, only the interpretation of the total score
can be recommended. This finding is in line with empir-
ical findings from other studies [28,29], which also rec-
ommend the use of the SCL-90-R as a screening
instrument using the global index. However, the present
study shows that the more economic short versions can
also be applied with similar psychometric properties,
particularly validity, in patients with affective disorders.
Furthermore, the reported empirical findings show
that the three-dimensional factor structure of the BSI-18
and the SCL-14 [8] was replicated. Therefore, from a
psychometric perspective, it can be concluded that the
BSI-18 and the SCL-14 are not only a more economic
alternative but can also be regarded as a psychometric
improvement. The SCL-K-9, with only 9 items, does not
have a broad range of measurement and only limitedly
contributes to the assessment of a wide range of psycho-
pathological symptoms within the context of a heteroge-
neous clinical sample. Moreover, the assessment of
changes within the therapy process, an important criter-
ion for outcome instruments, is also fulfilled across all
short versions.
A number of limitations of this study need to be
noted. The psychometric assessment was based on a
data set in which values of the short versions BSI, SCL-
27, BSI-18, SCL-14, and SCL-K-9 were calculated post-
hoc and may be intercorrelated. Our results showed high
correlations between the scores of the SCL-90-R and its
short versions. If we had advised the patients to fill out
the versions separately, this high intercorrelation may
have decreased. Nonetheless, this procedure appeared
feasible against the background of missing comparable
studies on patients with affective disorders. Further psy-
chometric assessments using individual applications of
the short versions BSI, SCL-27, BSI-18, SCL-14, and
SCL-K-9 should be carried out to support the reported
findings of this study. Regarding the generalisability of
our results, we compared the SCL-90-R and its short
versions in a widely representative sample of inpatients
with affective disorders undergoing psychotherapeutic
treatment in Germany. There is a need for the further
psychometric evaluation of patients with affective disor-
ders in other settings (e.g., outpatients, day clinics).
Conclusions
In summary, based on all empirical findings, the BSI-18
can be recommended as an economic variant and clinic-
ally meaningful instrument to measure symptom severity
in patients with affective disorders.Additional files
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